Enveric Biosciences Inc (ENVB) concluded trading on Thursday at a closing price of $0.39, with 3.56 million shares of worth about $1.39 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -24.65% during that period and on Thursday the price saw a gain of about 8.82%. Currently the company’s common shares owned by public are about 10.17M shares, out of which, 9.30M shares are available for trading.
Stock saw a price change of 25.81% in past 5 days and over the past one month there was a price change of 19.01%. Year-to-date (YTD), ENVB shares are showing a performance of 8.82% which decreased to -69.05% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.30 but also hit the highest price of $2.92 during that period. The average intraday trading volume for Enveric Biosciences Inc shares is 545.66K. The stock is currently trading 14.06% above its 20-day simple moving average (SMA20), while that difference is down -0.65% for SMA50 and it goes to -35.24% lower than SMA200.
Enveric Biosciences Inc (NASDAQ: ENVB) currently have 10.17M outstanding shares and institutions hold larger chunk of about 6.99% of that.
The stock has a current market capitalization of $3.96M and its 3Y-monthly beta is at 0.61. It has posted earnings per share of -$2.56 in the same period. It has Quick Ratio of 4.56 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ENVB, volatility over the week remained 12.11% while standing at 8.81% over the month.
